Skip to content

Clinical trials

Phase 3 Leukemia, Lymphocytic, Chronic, B-Cell trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Phase: Phase 3 Country / region: Brazil Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20095
20121
20132
20141
20151
20192
20211
20221
20234
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting7
Active, not recruiting6
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BeOne Medicines5
Hoffmann-La Roche5
Merck Sharp & Dohme LLC3
Acerta Pharma BV2
Janssen Research & Development, LLC2
Loxo Oncology, Inc.2
Novartis Pharmaceuticals2
AstraZeneca1
Celgene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell23
Leukemia, B-Cell4
Hematologic Diseases2
Lymphoma, B-Cell2
Lymphoma, Non-Hodgkin2
Neoplasms2
Recurrence2
Bronchiolitis Obliterans Syndrome1
Leukemia1
Leukemia, Lymphoid1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.